» Articles » PMID: 33608723

Bi-atrial High-density Mapping Reveals Inhibition of Wavefront Turning and Reduction of Complex Propagation Patterns As Main Antiarrhythmic Mechanisms of Vernakalant

Overview
Journal Europace
Date 2021 Feb 20
PMID 33608723
Citations 3
Authors
Affiliations
Soon will be listed here.
Abstract

Aims: Complex propagation patterns are observed in patients and models with stable atrial fibrillation (AF). The degree of this complexity is associated with AF stability. Experimental work suggests reduced wavefront turning as an important mechanism for widening of the excitable gap. The aim of this study was to investigate how sodium channel inhibition by vernakalant affects turning behaviour and propagation patterns during AF.

Methods And Results: Two groups of 8 goats were instrumented with electrodes on the left atrium, and AF was maintained by burst pacing for 3 or 22 weeks. Measurements were performed at baseline and two dosages of vernakalant. Unipolar electrograms were mapped (249 electrodes/array) on the left and right atrium in an open-chest experiment. Local activation times and conduction vectors, flow lines, the number of fibrillation waves, and local re-entries were determined. At baseline, fibrillation patterns contained numerous individual fibrillation waves conducting in random directions. Vernakalant induced conduction slowing and cycle length prolongation and terminated AF in 13/15 goats. Local re-entries were strongly reduced. Local conduction vectors showed increased preferential directions and less beat-to-beat variability. Breakthroughs and waves were significantly reduced in number. Flow line curvature reduced and waves conducted more homogenously in one direction. Overall, complex propagation patterns were strongly reduced. No substantial differences in drug effects between right and left atria or between goats with different AF durations were observed.

Conclusions: Destabilization of AF by vernakalant is associated with a lowering of fibrillation frequency and inhibition of complex propagation patterns, wave turning, local re-entries, and breakthroughs.

Citing Articles

"Pharmacological" analysis of atrial fibrillation maintenance mechanism: reentry, wavelets, or focal?.

Burashnikov A Front Cardiovasc Med. 2025; 12:1447542.

PMID: 39925977 PMC: 11802512. DOI: 10.3389/fcvm.2025.1447542.


Analysis of drug-induced and spontaneous cardioversions reveals similar patterns leading to termination of atrial fibrillation.

van Hunnik A, Sobota V, Zeemering S, Opacic D, Scaf B, DAlessandro E Front Physiol. 2024; 15:1399037.

PMID: 39092426 PMC: 11291310. DOI: 10.3389/fphys.2024.1399037.


25 years of basic and translational science in EP Europace: novel insights into arrhythmia mechanisms and therapeutic strategies.

Remme C, Heijman J, Gomez A, Zaza A, Odening K Europace. 2023; 25(8).

PMID: 37622575 PMC: 10450791. DOI: 10.1093/europace/euad210.


Electrophysiological and Structural Remodeling of the Atria in a Mouse Model of Troponin-I Mutation Linked Hypertrophic Cardiomyopathy: Implications for Atrial Fibrillation.

Lim W, Neo M, Thanigaimani S, Kuklik P, Ganesan A, Lau D Int J Mol Sci. 2021; 22(13).

PMID: 34203369 PMC: 8267948. DOI: 10.3390/ijms22136941.

References
1.
Nattel S, Kneller J, Zou R, Leon L . Mechanisms of termination of atrial fibrillation by Class I antiarrhythmic drugs: evidence from clinical, experimental, and mathematical modeling studies. J Cardiovasc Electrophysiol. 2004; 14(10 Suppl):S133-9. DOI: 10.1046/j.1540.8167.90302.x. View

2.
Lee G, Kumar S, Teh A, Madry A, Spence S, Larobina M . Epicardial wave mapping in human long-lasting persistent atrial fibrillation: transient rotational circuits, complex wavefronts, and disorganized activity. Eur Heart J. 2013; 35(2):86-97. DOI: 10.1093/eurheartj/eht267. View

3.
Podziemski P, Zeemering S, Kuklik P, van Hunnik A, Maesen B, Maessen J . Rotors Detected by Phase Analysis of Filtered, Epicardial Atrial Fibrillation Electrograms Colocalize With Regions of Conduction Block. Circ Arrhythm Electrophysiol. 2018; 11(10):e005858. PMC: 6553551. DOI: 10.1161/CIRCEP.117.005858. View

4.
Wettwer E, Christ T, Endig S, Rozmaritsa N, Matschke K, Lynch J . The new antiarrhythmic drug vernakalant: ex vivo study of human atrial tissue from sinus rhythm and chronic atrial fibrillation. Cardiovasc Res. 2013; 98(1):145-54. DOI: 10.1093/cvr/cvt006. View

5.
Jalife J . Déjà vu in the theories of atrial fibrillation dynamics. Cardiovasc Res. 2010; 89(4):766-75. PMC: 3105592. DOI: 10.1093/cvr/cvq364. View